Futura Medical (LON:FUM) Releases Earnings Results

Futura Medical (LON:FUM) announced its quarterly earnings results on Tuesday. The company reported GBX 0.43 ($0.01) EPS for the quarter, Digital Look Earnings reports. Futura Medical had a negative return on equity of 56.44% and a negative net margin of 44.64%.

Futura Medical Stock Up 6.9 %

Shares of FUM stock opened at GBX 9.57 ($0.13) on Tuesday. The stock has a market cap of £29.82 million, a P/E ratio of -7.89 and a beta of 1.25. Futura Medical has a fifty-two week low of GBX 8.47 ($0.11) and a fifty-two week high of GBX 45.56 ($0.60). The business has a fifty day simple moving average of GBX 11.81 and a 200-day simple moving average of GBX 25.35.

Futura Medical Company Profile

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.